Olimel N9 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N9 provides amino‑acid supplementation that supports metabolic pathways in several clinical situations.

• Inborn errors of metabolism: helps meet amino‑acid requirements when endogenous synthesis is impaired.
• Post‑surgical recovery: contributes to protein synthesis and tissue repair.
• Chronic kidney disease: assists in managing protein‑energy wasting by providing tailored amino‑acid profiles.
• Oncology supportive care: aids in maintaining lean body mass during chemotherapy.
• Severe malnutrition: supplies essential amino acids to support overall nutritional status.

• The amino‑acid blend supplies the body with substrates required for protein synthesis, nitrogen balance, and the production of neurotransmitters and metabolic intermediates. By delivering both essential and conditionally essential amino acids, the formulation supports cellular growth, tissue repair, and metabolic homeostasis across a range of physiological stress states.

Amino‑acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild gastrointestinal discomfort.
• Vomiting: occasional emesis after ingestion.
• Diarrhea: loose stools in sensitive individuals.
• Abdominal pain: cramping or discomfort.
• Metallic taste: transient alteration in taste perception.
• Headache: mild, self‑limiting.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, or swelling.
• Anaphylaxis: severe, potentially life‑threatening hypersensitivity.
• Hyperammonemia: elevated blood ammonia in patients with severe liver dysfunction.
• Metabolic acidosis: rare disturbance of acid‑base balance.
• Electrolyte imbalance: abnormal serum potassium or calcium levels.
• Renal impairment worsening: potential accumulation in patients with advanced kidney disease.

When prescribing Olimel N9, consider patient‑specific factors and monitor relevant parameters.

• Renal function: assess baseline creatinine and adjust use in severe impairment.
• Hepatic function: evaluate liver status, especially in patients prone to hyperammonemia.
• Metabolic disorders: avoid in uncontrolled inborn errors of metabolism.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Concomitant nutrition therapy: coordinate with total protein intake to prevent excess.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino‑acid formulations can influence the absorption or metabolism of certain medicines.

Major Interactions (Avoid)

• Levothyroxine: may reduce oral absorption; separate dosing by at least 4 hours.
• Anticonvulsants (e.g., phenytoin): potential alteration of plasma levels.
• Iron supplements: chelation can decrease amino‑acid availability.

Moderate Interactions (Monitor Closely)

• Diuretics: monitor electrolytes due to possible shifts.
• Insulin or oral hypoglycemics: watch for changes in glucose control.
• Antibiotics (e.g., tetracycline): may bind amino acids, reducing efficacy.